Russell Investments Group
MTEM

Russell Investments Group’s Molecular Templates, Inc. MTEM Stock Holding History

Russell Investments Group’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-834
Closed -$11K – 3004
2022
Q2 		$11K Sell
834
-29,709
-97% -$695K ﹤0.01% 2843
2022
Q1 		$1.58M Buy
30,543
+11,639
+62% +$514K ﹤0.01% 1745
2021
Q4 		$1.11M Buy
18,904
+1,237
+7% +$92.7K ﹤0.01% 2098
2021
Q3 		$1.78M Sell
17,667
-1,012
-5% -$104K ﹤0.01% 1900
2021
Q2 		$2.19M Buy
18,679
+15,789
+546% +$2.07M ﹤0.01% 1857
2021
Q1 		$546K Sell
2,890
-509
-15% -$89.2K ﹤0.01% 2490
2020
Q4 		$478K Sell
3,399
-270
-7% -$39.9K ﹤0.01% 2449
2020
Q3 		$599K Buy
3,669
+1,216
+50% +$216K ﹤0.01% 2312
2020
Q2 		$507K Sell
2,453
-1,813
-42% -$421K ﹤0.01% 2376
2020
Q1 		$852K Sell
4,266
-727
-15% -$159K ﹤0.01% 1924
2019
Q4 		$1.05M Buy
4,993
+2,667
+115% +$383K ﹤0.01% 2073
2019
Q3 		$230K Buy
+2,326
New +$217K ﹤0.01% 2549

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Russell Investments Group's MTEM Position: Q3 2022 in Review

Russell Investments Group sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 834 shares — an estimated $11K sold.

Russell Investments Group first reported a position in MTEM in Q3 2019 and held it in 12 quarters. The position peaked at $2.19M in Q2 2021. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

  • Russell Investments Group reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
  • Russell Investments Group sold 834 Molecular Templates, Inc. shares in Q3 2022, an estimated $11K.
  • Russell Investments Group first reported a position in Molecular Templates, Inc. in Q3 2019 and held it in 12 quarters.
  • Russell Investments Group's Molecular Templates, Inc. position peaked at $2.19M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.